Cargando…

Variation in the gene coding for the M5 Muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults

BACKGROUND: The mesolimbic structures of the brain are important in the anticipation and perception of reward. Moreover, many drugs of addiction elicit their response in these structures. The M5 muscarinic receptor (M5R) is expressed in dopamine-containing neurones of the substantia nigra pars compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Anney, Richard JL, Lotfi-Miri, Mehrnoush, Olsson, Craig A, Reid, Sophie C, Hemphill, Sheryl A, Patton, George C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1978498/
https://www.ncbi.nlm.nih.gov/pubmed/17608938
http://dx.doi.org/10.1186/1471-2156-8-46
_version_ 1782135406199832576
author Anney, Richard JL
Lotfi-Miri, Mehrnoush
Olsson, Craig A
Reid, Sophie C
Hemphill, Sheryl A
Patton, George C
author_facet Anney, Richard JL
Lotfi-Miri, Mehrnoush
Olsson, Craig A
Reid, Sophie C
Hemphill, Sheryl A
Patton, George C
author_sort Anney, Richard JL
collection PubMed
description BACKGROUND: The mesolimbic structures of the brain are important in the anticipation and perception of reward. Moreover, many drugs of addiction elicit their response in these structures. The M5 muscarinic receptor (M5R) is expressed in dopamine-containing neurones of the substantia nigra pars compacta and ventral tegmental area, and regulates the release of mesolimbic dopamine. Mice lacking M5R show a substantial reduction in both reward and withdrawal responses to morphine and cocaine. The CHRM5, the gene that codes for the M5R, is a strong biological candidate for a role in human addiction. We screened the coding and core promoter sequences of CHRM5 using denaturing high performance liquid chromatography to identify common polymorphisms. Additional polymorphisms within the coding and core promoter regions that were identified through dbSNP were validated in the test population. We investigated whether these polymorphisms influence substance dependence and dose in a cohort of 1947 young Australians. RESULTS: Analysis was performed on 815 participants of European ancestry who were interviewed at wave 8 of the cohort study and provided DNA. We observed a 26.8% increase in cigarette consumption in carriers of the rs7162140 T-allele, equating to 20.1 cigarettes per week (p=0.01). Carriers of the rs7162140 T-allele were also found to have nearly a 3-fold increased risk of developing cannabis dependence (OR=2.9 (95%CI 1.1-7.4); p=0.03). CONCLUSION: Our data suggest that variation within the CHRM5 locus may play an important role in tobacco and cannabis but not alcohol addiction in European ancestry populations. This is the first study to show an association between CHRM5 and substance use in humans. These data support the further investigation of this gene as a risk factor in substance use and dependence.
format Text
id pubmed-1978498
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-19784982007-09-19 Variation in the gene coding for the M5 Muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults Anney, Richard JL Lotfi-Miri, Mehrnoush Olsson, Craig A Reid, Sophie C Hemphill, Sheryl A Patton, George C BMC Genet Research Article BACKGROUND: The mesolimbic structures of the brain are important in the anticipation and perception of reward. Moreover, many drugs of addiction elicit their response in these structures. The M5 muscarinic receptor (M5R) is expressed in dopamine-containing neurones of the substantia nigra pars compacta and ventral tegmental area, and regulates the release of mesolimbic dopamine. Mice lacking M5R show a substantial reduction in both reward and withdrawal responses to morphine and cocaine. The CHRM5, the gene that codes for the M5R, is a strong biological candidate for a role in human addiction. We screened the coding and core promoter sequences of CHRM5 using denaturing high performance liquid chromatography to identify common polymorphisms. Additional polymorphisms within the coding and core promoter regions that were identified through dbSNP were validated in the test population. We investigated whether these polymorphisms influence substance dependence and dose in a cohort of 1947 young Australians. RESULTS: Analysis was performed on 815 participants of European ancestry who were interviewed at wave 8 of the cohort study and provided DNA. We observed a 26.8% increase in cigarette consumption in carriers of the rs7162140 T-allele, equating to 20.1 cigarettes per week (p=0.01). Carriers of the rs7162140 T-allele were also found to have nearly a 3-fold increased risk of developing cannabis dependence (OR=2.9 (95%CI 1.1-7.4); p=0.03). CONCLUSION: Our data suggest that variation within the CHRM5 locus may play an important role in tobacco and cannabis but not alcohol addiction in European ancestry populations. This is the first study to show an association between CHRM5 and substance use in humans. These data support the further investigation of this gene as a risk factor in substance use and dependence. BioMed Central 2007-07-03 /pmc/articles/PMC1978498/ /pubmed/17608938 http://dx.doi.org/10.1186/1471-2156-8-46 Text en Copyright © 2007 Anney et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Anney, Richard JL
Lotfi-Miri, Mehrnoush
Olsson, Craig A
Reid, Sophie C
Hemphill, Sheryl A
Patton, George C
Variation in the gene coding for the M5 Muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults
title Variation in the gene coding for the M5 Muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults
title_full Variation in the gene coding for the M5 Muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults
title_fullStr Variation in the gene coding for the M5 Muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults
title_full_unstemmed Variation in the gene coding for the M5 Muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults
title_short Variation in the gene coding for the M5 Muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults
title_sort variation in the gene coding for the m5 muscarinic receptor (chrm5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1978498/
https://www.ncbi.nlm.nih.gov/pubmed/17608938
http://dx.doi.org/10.1186/1471-2156-8-46
work_keys_str_mv AT anneyrichardjl variationinthegenecodingforthem5muscarinicreceptorchrm5influencescigarettedosebutisnotassociatedwithdependencetodrugsofaddictionevidencefromaprospectivepopulationbasedcohortstudyofyoungadults
AT lotfimirimehrnoush variationinthegenecodingforthem5muscarinicreceptorchrm5influencescigarettedosebutisnotassociatedwithdependencetodrugsofaddictionevidencefromaprospectivepopulationbasedcohortstudyofyoungadults
AT olssoncraiga variationinthegenecodingforthem5muscarinicreceptorchrm5influencescigarettedosebutisnotassociatedwithdependencetodrugsofaddictionevidencefromaprospectivepopulationbasedcohortstudyofyoungadults
AT reidsophiec variationinthegenecodingforthem5muscarinicreceptorchrm5influencescigarettedosebutisnotassociatedwithdependencetodrugsofaddictionevidencefromaprospectivepopulationbasedcohortstudyofyoungadults
AT hemphillsheryla variationinthegenecodingforthem5muscarinicreceptorchrm5influencescigarettedosebutisnotassociatedwithdependencetodrugsofaddictionevidencefromaprospectivepopulationbasedcohortstudyofyoungadults
AT pattongeorgec variationinthegenecodingforthem5muscarinicreceptorchrm5influencescigarettedosebutisnotassociatedwithdependencetodrugsofaddictionevidencefromaprospectivepopulationbasedcohortstudyofyoungadults